6-Fluorospiro[4H-3,1-benzoxazine-4,4'-piperidin]-2(1H)-one

Catalog No.: 
ACJNSL807
CAS No.: 
92926-32-4
Molecular Formula: 
C12H13FN2O2
Molecular Weight: 
236.25
6-Fluorospiro[4H-3,1-benzoxazine-4,4'-piperidin]-2(1H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$196.00InquiryInquiry
5g95%$970.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Fluorospiro[4H-3,1-benzoxazine-4,4'-piperidin]-2(1H)-one
IUPAC Name6-fluorospiro[benzo[d][1,3]oxazine-4,4'-piperidin]-2(1H)-one
MDL No.F188348
Molecular FormulaC12H13FN2O2
Molecular Weight236.25
SMILESFC1=CC2=C(C=C1)NC(OC23CCNCC3)=O
InChI KeyZHRWOWCJMFGREP-UHFFFAOYSA-N
Synonym92926-32-4 | 6-Fluorospiro[4H-3,1-benzoxazine-4,4'-piperidin]-2(1H)-one | 6-fluorospiro[benzo[d][1,3]oxazine-4,4'-piperidin]-2(1H)-one | (6-Fluorospiro[4H-3,1-benzoxazine-4,4'-piperidin]-2(1H)-one) | 6-fluoro-1,2-dihydrospiro[3,1-benzoxazine-4,4'-piperidine]-2-on
CAS No.92926-32-4
PubChem CID13116156

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACJNSL807 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVXUB509 route compound structure diagram
    ACVXUB509345938-08-1In Stock
  2. Then
  3. ACJNSL807 route product structure diagram
    ACJNSL80792926-32-4
Inquiry

2. ACJNSL807 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJNSL807 route product structure diagram
    ACJNSL80792926-32-4
Inquiry

3. ACJNSL807 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJNSL807 route product structure diagram
    ACJNSL80792926-32-4
Inquiry

Comments (0)